Matteo S. Carlino

Researcher Next ID · RN-004666

Researcher · Medicine

Sydney, Australia

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Cancer Immunotherapy and Biomarkers

Melanoma and MAPK Pathways

Cutaneous Melanoma Detection and Management

CAR-T cell therapy research

Immunotherapy and Immune Responses

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1910836
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
JAMA Oncology · 2018 · https://doi.org/10.1001/jamaoncol.2018.3923
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709684
Pembrolizumab versus Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1503093
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030

No projects listed.